ADRX-0706, a Nectin-4-targeted antibody-drug conjugate, has earned FDA fast track designation in advanced cervical cancer.

On the morning of Nov. 16, 2023, Saanich resident Jumoke Brown, a 32-year-old education assistant, began his day as usual, ...

This new immunotherapy is particularly effective in several types of solid tumors, but it will take time to confirm its ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Up to half of cancers could be caught at a more treatable stage The blood test looks for DNA fragments shed by tumors and ...

Waukesha County Executive Paul Farrow had cancer surgery for a rare and aggressive cancer on March 14. He was diagnosed Aug. 21.

Innovative Maryland surgeons pioneer first-of-its-kind transorbital approach to remove spinal tumors, successfully treating a ...

Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why.

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

An AI-driven model trained on digital pathology slides accurately classified pediatric sarcoma subtypes in a multicenter ...